chrisvoncsefalvay/vaers-outcomes huggingface dataset:
panic had atrial fibrillation of which I have never had any heart issues at all; I actually blacked out for several minutes; I woke up at 2:00 am with chills; panic had atrial fibrillation of which I have never had any heart issues at all; This is a spontaneous report from a contactable consumer (patient)   A 58-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 05May2021 14:45 (Lot Number: Ew0172) as single dose (at the age of 58) for covid-19 immunisation. The first dose (lot#Ew0158) was administered arm right on 12Apr2021 04:00 pm. Medical history included blood pressure (the patient received within 2 weeks of vaccination: Blood pressure meds). The patient experienced panic had atrial fibrillation of which i have never had any heart issues at all on 06May2021 02:00 am, i actually blacked out for several minutes on 06May2021 02:00 am, i woke up at 2:00 am with chills on 06May2021 02:00. No treatment received. The events outcome was recovered with sequelae.  Follow-up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Initial overdose report received from a healthcare professional on 20 May 2013. A 4-month-old patient received PENTACEL and IPOL vaccine in the same visit. No adverse event was reported. List of documents held by sender: none.
devel 8x5cm area of redness around inj site;afeb seen by MD dx local rxn;
Muscle aches, headache, lethargic, severe pain in injection site, redness, swelling. Tylenol, rest, increased fluids, cold compresses on injection site. Vicks Vapor Rub with Lavender 4 days.
10/14/2010 mild other redness and swelling on bicep of right arm due to gravity. Pt. noted redness of PNEUMOVAX site on.
congestion, cough, chills, heachache, fatigue, loss of sense of taste and smell. Moderna dose in Dec 2020 and Jan 2021
Some trouble breathing (mucus in throat), which resolved by morning. 2-3 days of shoulder pain & swollen glands under arm. 1 week of headache and body aches without fever.
Patient received vaccination subcutaneously instead of intramuscularly.  I contacted Moderna and was informed that the dose did not need to be repeated and to inform the patient that she may experience local irritation.  We informed patient.
Left side of face paralysis- eyebrow, eyelid and mouth, pain in left ear.  Symptoms  left after 2 weeks.
Received multiple vaccinations on 12/28/11. Had witnessed acute syncopal episode. Brief LOC followed by severe nausea. No vomiting, (+) diaphoresis, (+) decreased BP 60/40, (+) thready pulse 50-60, (+) pallor, (-) seizure activity, (-) incontinence. Given Epinephrine .3 SC (1 to 1,000). 911 called. Transported to hosp.
Vaccine expired on 08/31/2022 and was given on 09/01/2022.
LOSS OF SMELL; WARM; LOSS OF TASTE; CHEST COLD; HEAD COLD; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight was 145 pounds, and height was 64 inches. The patient's concurrent conditions included alcohol user, and non-smoker, and the patient had no known allergies. The patient did not have any drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, expiry: UNKNOWN)  dose was not reported, 1 total, administered on 08-APR-2021 to left arm as prophylactic vaccination. No concomitant medications were reported.  On 07-JUL-2021, the patient had head cold and chest cold. On 10-JUL-2021, the patient had loss of smell, taste and was warm. On 13-JUL-2021, the patient was scheduled for COVID test. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from head cold, loss smell, warm, chest cold, and loss of taste. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 20210725918-COVID-19 VACCINE AD26.COV2.S-chest cold. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Within 24 hours of the vaccination PROQUAD, the had a tennis ball size circular lesion erythematous with blisters in the middle and indurated, and warm to the touch, no fever, no vomiting.
received the first dose / in May 2019 and has not received the second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in May 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided are as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient had not received her 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Narrative: 91 yo patient w/PMH significant for cardiomyopathy, hypertension, and hypothyroidism and s/p Pfizer COVID-19 vaccinations on 1/16/21 and 2/6/21 (21 days apart). Patient tested positive for COVID-19 on 3/23/21. Patient's daughter called the Facility requesting a COVID-19 test for patient after patient's wife tested positive for COVID-19. Per daughter, patient had a dry cough and runny nose starting 3/18/21. No treatment medications required, patient did not require hospitalization. Patient and daughter provided COVID-19 positive result and counseling by MD by phone on 3/25/21. Infection Control staff documented on 3/26/21 that case report and lab result faxed to Health Department + specimen collected 03/24/21. On 5/4/21, patient recently had a telephone general medicine clinic appt. MD documented: "says he is doing well other than just feels little weak. denies any fever/chills/chest apin/son. no abd pain/nausea/vomitting/diarrhea/malena. no urine problems.no leg edema.appetit ok.wt stable." On 10/20/21, patient received his 3rd pfizer COVID-19 vaccination without complications.
This non-serious spontaneous case, was initially received from other health professional on 27-Sep-2017, concerning a 61-year-old, adult, female patient. The patient's medical history and concomitant medications were not reported. On 19-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, batch number: 00444611A, expiry date: 30-Jun-2018, route of administration: intramuscular, anatomical location: right deltoid). On the same day, immediately after vaccination, the patient developed redness, a little bleeding, lump and rash around injection site. The patient could elevate arm and swelling seemed to diminish. It was reported that, after 15 minutes swelling was reduced, leaving just a little rash around the injection site. On 19-Sep-2017, the patient recovered from the events. The reporter assessed the report as non-serious. Follow-up received on 13-Oct-17: The vaccine administration details were updated (route of administration: intramuscular and anatomical location: right deltoid). Narrative amended accordingly. Non-significant case correction received with IRD 27-Sep-2017: Batch number (00444611A) was added on the screen and updated expiry date. The narrative was amended accordingly.
Developed red patchy rash to both legs.  Described as "hives" but really red and patchy.  Given Benadryl.  Rash resolved on own.  Parents did not call our office and did not report this to us until today.
Narrative: Beginning around 2am in the morning after my vaccine, I had extreme swelling of my right upper arm, muscle felt hard and hot, skin turned dark red/purple. Arm was painful with burning sensation that radiated all the way to my  fingers. This continued to grow worse with swelling expanding down to my elbow and across to my right breast by the next day. I took pain relievers and Benadryl to manage, but honestly, the Benadryl just helped me sleep. Mild fever, headache,  upset stomach and general malaise were also experienced. Symptoms continued over the weekend, although the swelling and skin discoloration appear to be resolving. Unfortunately, the neuropathy in my right arm- down to my right fingertips continues and I would rate this as moderate and continuous.
Patient stated that 1 hr after immunization she developed a headache and vision problems (blurred vision and flashing) that lasted approx. 3 hours. Also reported a line under injection site that was red, hot, and itchy and had burning pain in the area. She stated rash was slowly diminishing.
Flu like symptoms; Fever  105.1 degree Farad; Initial information was received on 08-Jun-2021 regarding an unsolicited valid  non-serious case from a consumer/non-health care professional.  This case involves a patient (demographics unknown) who experienced fever  105.1 degree Farad (pyrexia) and flu like symptoms (influenza like illness) after receiving YELLOW FEVER VACCINE [YF-VAX].  The patient had no medical history, concomitant disease or risk factor  Medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date back in January, the patient received a dose of suspect YELLOW FEVER VACCINE lot number not reported via unknown route in unknown administration site for prophylactic vaccination, due to a job requirement.  On an unknown date the patient developed a non-serious fever  105.1 degree farad (pyrexia) and flu like symptoms (influenza like illness) (unknown latency) following the administration of YELLOW FEVER VACCINE. The patient had to go to the emergency room  (ER ) to manage the symptoms  It was unknown if the patient experienced any additional symptoms/events.  No other relevant test was reported  It was not reported if the patient received a corrective treatment for the events   At time of reporting, the outcome of events was unknown.  The reporter did not report causality of events with suspect  There will be no information available on the batch number for this case.
Newborn boy received Hep-B vaccine (5mg IM). Less that 10 minutes, post vax, RN noticed baby was cyanotic. Pt was stimulated and given O2 by face mask. The baby responded and was transferred to NICU. Baby was discharged on 7/15/01.
PAIN/ACHING JOINTS OF HIPS, KNEES AND ANKLES; This spontaneous report received from a patient concerned a 52 year old male. The patient's weight was 238 pounds, and height was 74 inches. The patient's concurrent conditions included polymyalgic rheumatica, blood pressure, non-smoker, alcohol use, nut allergy, milk allergy, egg allergy, potato allergy, wheat allergy, orange allergy, food allergies resulted in rash, and food allergy resulted in runny nose, and other pre-existing medical conditions included caller reports he takes blood pressure meds, vitamins, humira for polymyalgic rheumatica, and also unnamed "add medicine". The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, and expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 18:00 on left arm for prophylactic vaccination. Concomitant medications included adalimumab for polymyalgia rheumatica. On 11-MAR-2021, the subject experienced pain/aching joints of hips, knees and ankles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain/aching joints of hips, knees and ankles. This report was non-serious.
Fatigue, achiness, horrible headache and horrible cough, rough throat, no fever.
Fever (101), headache, body aches, fatigue.  Lastes 2 1/2 days.
Patient reported that two days after receiving the Moderna Omicron Booster he had "excruciating pain" radiating in his right upper back that he attributes to the vaccine.
Numbness left side of face and arm down to fingertips.; Metal taste in mouth; Red spot about a quarter size around the injection site; This is a spontaneous report from a contactable consumer or other non hcp. A 52-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number; EL3302) via an unspecified route of administration, administered in Arm Left on 23Feb2021 11:30 (at the age of 52-Years-old) as dose 2, single for COVID-19 immunisation. Facility where the most recent COVID-19 vaccine was administered reported as Public Health Clinic/Veterans Administration facility. Medical history included known allergies for an unspecified indication with unspecified start and stop date. Concomitant medication(s) included dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL) taken for an unspecified indication, start and stop date were not reported. The patient previously took BNT162B2 (Lot number: EK9231) via an unspecified route of administration, administered in Arm Left on 26Jan2021 (at the age of 52-Years-old) as dose 1, single for COVID-19 immunisation. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine (prior vaccination was none). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Past drugs included Hydrocodone, Percodan, Percoset, Codeine, Dilaudid, Alleve, Sanitizer, Cannabis. The patient experienced numbness left side of face and arm down to fingertips, metal taste in mouth and red spot about a quarter size around the injection site on 23Feb2021. AE was resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No treatment was received for the reported events. The outcome of the events were not recovered.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021227872 similar report from same reporter
HEADACHE; FEVER; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced headache, fever, and fatigue. The action taken with covid-19 vaccine was not applicable. The outcome of the headache, fever and fatigue was not reported. This report was non-serious. This case, from the same reporter is linked to 20210624217 and 20210627468.
Throat started closing, face swelling, coughing & went to E.R. Got BENADRYL shot. Went to E.R. approximately 4 hrs later.
Patient received Janssen COVID-19 vaccine on 7-11-22 approximately 4:30 pm. As she was waiting in the pharmacy observation area, she lost consciousness at approximately 4:45 pm. Pharmacy team members responded immediately and summoned EMS. Patient was experiencing respiratory distress and 3 Epi-pens were administered to get her breathing and conscious again. EMS arrived shortly thereafter and took control of the scene. Patient was transported to the hospital.
During the week following the first Covid 19 2/1/21 I had a couple of days with Migraine and the ?normal symptoms ? but increasingly feeling winded and nauseous.  I also had a couple of days at the end of the week where I had severe leg cramps.  I found myself with low blood oxygen and high resting pulse so on Monday 2/8/21, after a phone conference with Dr. she sent me to the ER At Hospital , where they kept me until the following Thursday.  I had a Pumonary Embolus and respiratory failure.  They preformed  Trombolysis.
half dollar sized, warm to touch swelling at the injection site; half dollar sized, warm to touch swelling at the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE WARMTH (half dollar sized, warm to touch swelling at the injection site) and VACCINATION SITE SWELLING (half dollar sized, warm to touch swelling at the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE WARMTH (half dollar sized, warm to touch swelling at the injection site) and VACCINATION SITE SWELLING (half dollar sized, warm to touch swelling at the injection site). At the time of the report, VACCINATION SITE WARMTH (half dollar sized, warm to touch swelling at the injection site) and VACCINATION SITE SWELLING (half dollar sized, warm to touch swelling at the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was provided.  No concomitant product was provided by the reporter. Action taken with mRNA-123 is not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. Injection site swelling is consistent with the product safety profile
pt recv vax 19JUL96 & post vax pt immed exp SOB, pressure from chest up to scalp & non-specific EKG changes in the S-T interval;sx resolved p/a trip to the ER;
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 20-OCT-2012 13:13, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Patient received vaccinations, including Pediarix (#2), HIB (#2), Rotateq (#2), Prevnar (#2). He cried vigorously and then settled down. Mother was dressing him to leave ~2-3 minutes after the shots were given and he went limp in her arms. I arrived immediately to find the child weakly responsive. He maintained his heart rate (100-110) and respirations throughout the episode. He would open his eyes to sternal rub and then fall back into decreased consciousness. No posturing or clonic movements noted. After ~5-10 minutes he regained consciousness and was interactive and cried for his bottle, which he took well. 12/7/07-records received for DOS 11/9/07-pesents with 1 episode of LOC x 2 min while at clinic. Episode was not accompanied by jerking. Eyes rolled back. Impression: episode of loss of consciousness. Differential includes breath holding spell, syncope, seizure secondary to cough medicine.
Below shot site a small knot formed under the skin  exactly 2 weeks following  first dose.  On day 15,  site became reddened and  raised  (appearance similar to hives). Raised area was about the size of a quarter on day 15.  It has progressed to  about 4.5-5 inches in diameter as of today.
Patient stated that after receiving vaccine, he went home and took a nap. About 2 hours after receiving vaccine he had sharp shoulder pain. He claims that the shoulder pain continues and will not go away. He claimed he has trouble lifting his arm above shoulder height.
lost sense of smell; lost sense of taste; lost her appetite, doesn't feel like eating anything; still has soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (lost sense of smell), AGEUSIA (lost sense of taste), DECREASED APPETITE (lost her appetite, doesn't feel like eating anything) and VACCINATION SITE PAIN (still has soreness at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANOSMIA (lost sense of smell), AGEUSIA (lost sense of taste), DECREASED APPETITE (lost her appetite, doesn't feel like eating anything) and VACCINATION SITE PAIN (still has soreness at the injection site). At the time of the report, ANOSMIA (lost sense of smell), AGEUSIA (lost sense of taste), DECREASED APPETITE (lost her appetite, doesn't feel like eating anything) and VACCINATION SITE PAIN (still has soreness at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Weight: lost 10 lbs (Low) lost 10 lbs.         No relevant concomitant medications reported.  No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
The 15 year old child received the vaccine for 5 to 11 year old's. No adverse reaction noted. PCP Dr. did not recommend any action be taken.
11 moths old received Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-month-old male patient who received DTPa-IPV (Kinrix) (batch number C472T, expiry date 22nd March 2024) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th November 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 10th November 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 7-Dec-2022 Reporter's comment: The reporter consented to follow-up. The case was for 5 of 5 linked patients reported by same reporter. Additional supportive information: The patient received a dose of Kinrix at inappropriate age, which led to inappropriate age at vaccine administration. Thanks and regards,; Sender's Comments:  US-GSK-US2022183609:Same reporter US-GSK-US2022183610:Same reporter US-GSK-US2022183611:Same reporter US-GSK-US2022183612:Same reporter
18JUL91 7AM hives, none @ 5AM, slight rash on face; hives persisted into PM; checked by MD no tx;
Immediate headache and sore throat, light-headed. 2 Days later experienced vertigo while laying down,  some nausea, vision more blurred, for a split second, could not see out of the center of my left eye, when room was dark, no issues with light on. I know sounds weird, but freaked me out. I wear glasses so vision was always a little blurred but it is worse now. I'm nearsighted but now that is a little blurry too. Eyes more sensitive to light to the point of where it hurts if I'm in bright sunlight or a brightly Lit room. Although my left eye doesn't always hurt, it feels different. Always aware of it. Don't know how to explain it.